Daniel A. Alicata to Amphetamine-Related Disorders
This is a "connection" page, showing publications Daniel A. Alicata has written about Amphetamine-Related Disorders.
Connection Strength
0.914
-
Alicata D, Chang L, Cloak C, Abe K, Ernst T. Higher diffusion in striatum and lower fractional anisotropy in white matter of methamphetamine users. Psychiatry Res. 2009 Oct 30; 174(1):1-8.
Score: 0.331
-
Kogachi S, Chang L, Alicata D, Cunningham E, Ernst T. Sex differences in impulsivity and brain morphometry in methamphetamine users. Brain Struct Funct. 2017 01; 222(1):215-227.
Score: 0.131
-
Ling W, Chang L, Hillhouse M, Ang A, Striebel J, Jenkins J, Hernandez J, Olaer M, Mooney L, Reed S, Fukaya E, Kogachi S, Alicata D, Holmes N, Esagoff A. Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder. Addiction. 2014 Sep; 109(9):1489-500.
Score: 0.115
-
Cloak CC, Alicata D, Chang L, Andrews-Shigaki B, Ernst T. Age and sex effects levels of choline compounds in the anterior cingulate cortex of adolescent methamphetamine users. Drug Alcohol Depend. 2011 Dec 15; 119(3):207-15.
Score: 0.094
-
King G, Alicata D, Cloak C, Chang L. Neuropsychological deficits in adolescent methamphetamine abusers. Psychopharmacology (Berl). 2010 Oct; 212(2):243-9.
Score: 0.088
-
King G, Alicata D, Cloak C, Chang L. Psychiatric symptoms and HPA axis function in adolescent methamphetamine users. J Neuroimmune Pharmacol. 2010 Dec; 5(4):582-91.
Score: 0.086
-
Chang L, Alicata D, Ernst T, Volkow N. Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction. 2007 Apr; 102 Suppl 1:16-32.
Score: 0.070